Skip to main content

Eli Lilly & Co

LLY
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000059478

In the last 90 days, Eli Lilly & Co insiders filed 0 open-market purchases and 3 sales; 4,643 institutions reported holding it in 13F filings for Q2 2026, worth $942.7B in total; 4 superinvestors hold it, including ARK Invest and Soros Fund Management.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Eli Lilly & Co insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
3 insiders, $16.0M in total
Insiders trading
3
Net value
−$16.0M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Eli Lilly & Co, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Eli Lilly & Co
NameTitleLast reported holdingLast filingFilings, past year
Sulzberger GabrielleDirector3,012Sep 22, 202612
Luciano Juan RDirector16,957Sep 22, 202612
Fyrwald J ErikDirector75,536Sep 22, 202612
Alvarez RalphDirector55,838Sep 22, 202612
Seymour MelissaEVP, Global Quality1,038Sep 11, 20262
Hernandez EdgardoEVP & Pres., Mfg. Operations46,083Sep 4, 20263
Dozier EricEVP, Chief People Officer14,239Sep 4, 20264
Jonsson PatrikEVP & President, LLY Int'l54,147Aug 18, 20263
Zakrowski Donald ASVP, Finance, & CAO1,526Aug 11, 20264
Hakim AnatEVP, GC & Secretary11,875IndirectAug 10, 20263
Yuffa IlyaEVP&Pres, LLY USA&Global Capab29,804Jun 11, 20263
Lilly Endowment IncOther: Former 10% Shareholder91,881,150May 7, 202634
Montarce LucasEVP & CFO16,258Feb 18, 20262
Custer Kenneth L.EVP & President, Card Met Hlth10,141Feb 18, 20262
Brown Adrienne SEVP, President LLY Imm5,142Feb 18, 20262
Rau DiogoEVP & CIDO26,397Feb 12, 20262
Ricks David APresident, Chair, and CEO571,715Feb 11, 20263
Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBD26,627Feb 11, 20262
Skovronsky DanielEVP, CS&PO & Pres. LRL160,072Feb 11, 20263
Hedley Mary LynneDirector2,253Dec 16, 20253
Moeller Jon RDirector304Nov 18, 20251
Baicker KatherineDirector23,503Nov 18, 20251
Kaelin William G JrDirector21,837Nov 18, 20251
Jackson JamereDirector9,635Nov 18, 20251
Johnson Kimberly HDirector3,265Nov 18, 20251
White Anne E.EVP & Pres, Lilly Neuroscience74,210Feb 12, 20250
Walker KarenDirector6,249Nov 20, 20240
Norton JohnaEVP, Global Quality25,428Jun 3, 20240
Ashkenazi AnatEVP & CFO42,330Feb 14, 20240
Weems AlonzoEVP, ERM & CECO7,951Feb 14, 20240
Runge Marschall SDirector16,593Nov 21, 20230
Tai Jackson PDirector63,524Apr 19, 20230
Pusey Leigh AnnEVP, Corp. Affairs & Comm.31,641Feb 14, 20230
Mason Michael BEVP & Pres., Lilly Diabetes39,284Feb 14, 20230
Fry Stephen FSVP, HR & Diversity152,631Feb 11, 20220
Eskew Michael LDirector45,080Nov 17, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 18, 2026 (view filing)4:20 PM ETAug 171 dayJonsson PatrikEVP & President, LLY Int'lSSale−6.50K$1,175.10−$7.64M−10.7%54.1K after10b5-1
Aug 11, 2026 (view filing)4:31 PM ETAug 101 dayZakrowski Donald ASVP, Finance, & CAOSSale−2.00K$1,185.01−$2.37M−56.7%1.53K after10b5-1
Aug 10, 2026 (view filing)4:19 PM ETAug 73 daysHakim AnatEVP, GC & SecretarySSale−5.00K$1,190.00−$5.95M−29.6%11.9K after10b5-1
Jun 11, 2026 (view filing)Jun 101 dayYuffa IlyaEVP&Pres, LLY USA&Global CapabSSale−2.50K$1,150.77−$2.88M−7.7%29.8K after10b5-1
May 7, 2026 (view filing)May 61 dayLilly Endowment IncOther: Former 10% ShareholderSSale−15.8K$995.36−$15.8M0.0%91.9M after2 lots
Jan 8, 2026 (view filing)Jan 71 dayLilly Endowment Inc10% OwnerSSale−292.1K$1,103.48−$322.4M−0.3%91.9M after30 lots
Jan 6, 2026 (view filing)Jan 51 dayLilly Endowment Inc10% OwnerSSale−1.39K$1,085.01−$1.51M0.0%92.2M after
Dec 30, 2025 (view filing)Dec 291 dayLilly Endowment Inc10% OwnerSSale−3.59K$1,085.04−$3.90M0.0%92.2M after
Dec 29, 2025 (view filing)Dec 245 daysLilly Endowment Inc10% OwnerSSale−2.63K$1,085.17−$2.85M0.0%92.2M after
Dec 29, 2025 (view filing)Dec 236 daysLilly Endowment Inc10% OwnerSSale−240$1,085.04−$260.4K0.0%92.2M after
Nov 26, 2025 (view filing)Nov 251 dayLilly Endowment Inc10% OwnerSSale−15.6K$1,109.30−$17.3M0.0%92.2M after3 lots
Nov 26, 2025 (view filing)Nov 251 dayLilly Endowment Inc10% OwnerSSale−147.1K$1,095.35−$161.1M−0.2%92.2M after30 lots
Nov 25, 2025 (view filing)Nov 241 dayLilly Endowment Inc10% OwnerSSale−142.3K$1,068.53−$152.1M−0.2%92.4M after6 lots
Nov 24, 2025 (view filing)Nov 213 daysLilly Endowment Inc10% OwnerSSale−105.3K$1,058.66−$111.5M−0.1%92.5M after17 lots
Nov 21, 2025 (view filing)Nov 201 dayLilly Endowment Inc10% OwnerSSale−37.1K$1,051.66−$39.1M0.0%92.6M after6 lots
Nov 20, 2025 (view filing)Nov 191 dayLilly Endowment Inc10% OwnerSSale−167.5K$1,051.17−$176.1M−0.2%92.6M after6 lots
Nov 19, 2025 (view filing)Nov 181 dayLilly Endowment Inc10% OwnerSSale−60.2K$1,034.78−$62.3M−0.1%92.8M after10 lots
Nov 18, 2025 (view filing)Nov 171 dayLilly Endowment Inc10% OwnerSSale−9.89K$1,030.68−$10.2M0.0%92.9M after2 lots
Nov 17, 2025 (view filing)Nov 143 daysLilly Endowment Inc10% OwnerSSale−178.3K$425,738.48−$75.9B−0.2%92.9M after4 lotsPrice outlier
Nov 14, 2025 (view filing)Nov 131 dayLilly Endowment Inc10% OwnerSSale−46.6K$1,030.26−$48.0M−0.1%93.1M after2 lots
Nov 13, 2025 (view filing)Nov 13Same dayZakrowski Donald ASVP, Finance, & CAOSSale−1.00K$1,010.50−$1.01M−26.0%2.84K after10b5-1
Nov 13, 2025 (view filing)Nov 121 dayLilly Endowment Inc10% OwnerSSale−305.0K$1,011.19−$308.4M−0.3%93.1M after20 lots
Nov 12, 2025 (view filing)Nov 111 dayLilly Endowment Inc10% OwnerSSale−283.1K$986.64−$279.3M−0.3%93.4M after27 lots
Nov 12, 2025 (view filing)Nov 102 daysLilly Endowment Inc10% OwnerSSale−16.9K$972.52−$16.4M0.0%93.7M after3 lots
Nov 6, 2025 (view filing)Nov 51 dayLilly Endowment Inc10% OwnerSSale−40.4K$951.56−$38.5M0.0%93.7M after8 lots
Nov 6, 2025 (view filing)Nov 51 dayLilly Endowment Inc10% OwnerSSale−179.0K$933.26−$167.1M−0.2%93.8M after30 lots
Nov 5, 2025 (view filing)Nov 41 dayLilly Endowment Inc10% OwnerSSale−526$910.72−$479.0K0.0%93.9M after
Nov 4, 2025 (view filing)Nov 31 dayLilly Endowment Inc10% OwnerSSale−300.0K$888.83−$266.6M−0.3%93.9M after24 lots
Nov 3, 2025 (view filing)Oct 313 daysLilly Endowment Inc10% OwnerSSale−301.3K$863.35−$260.2M−0.3%94.2M after8 lots
Oct 14, 2025 (view filing)Oct 104 daysLilly Endowment Inc10% OwnerSSale−3.66K$863.24−$3.16M0.0%94.5M after2 lots
Oct 10, 2025 (view filing)Oct 91 dayLilly Endowment Inc10% OwnerSSale−10.6K$852.49−$9.04M0.0%94.5M after8 lots
Oct 9, 2025 (view filing)Oct 81 dayLilly Endowment Inc10% OwnerSSale−101.4K$850.28−$86.2M−0.1%94.5M after8 lots
Oct 8, 2025 (view filing)Oct 71 dayLilly Endowment Inc10% OwnerSSale−26.8K$848.01−$22.7M0.0%94.6M after
Oct 7, 2025 (view filing)Oct 61 dayLilly Endowment Inc10% OwnerSSale−161.2K$850.22−$137.0M−0.2%94.7M after8 lots
Oct 6, 2025 (view filing)Oct 33 daysLilly Endowment Inc10% OwnerSSale−192.4K$837.93−$161.2M−0.2%94.8M after25 lots
Oct 3, 2025 (view filing)Oct 21 dayLilly Endowment Inc10% OwnerSSale−112.6K$821.55−$92.5M−0.1%95.0M after9 lots
Oct 2, 2025 (view filing)Oct 11 dayLilly Endowment Inc10% OwnerSSale−215.8K$821.47−$177.3M−0.2%95.1M after25 lots
Oct 2, 2025 (view filing)Oct 11 dayLilly Endowment Inc10% OwnerSSale−135.2K$794.15−$107.4M−0.1%95.4M after30 lots
Oct 1, 2025 (view filing)Sep 301 dayLilly Endowment Inc10% OwnerSSale−113.7K$763.40−$86.8M−0.1%95.5M after4 lots
Sep 22, 2025 (view filing)Sep 193 daysLilly Endowment Inc10% OwnerSSale−23.7K$763.09−$18.1M0.0%95.6M after2 lots
Sep 19, 2025 (view filing)Sep 181 dayLilly Endowment Inc10% OwnerSSale−106.6K$764.65−$81.5M−0.1%95.6M after5 lots
Aug 28, 2025 (view filing)Aug 28Same dayZakrowski Donald ASVP, Finance, & CAOSSale−1.00K$734.93−$734.9K−20.7%3.84K after10b5-1
Aug 15, 2025 (view filing)Aug 15Same dayMontarce LucasEVP & CFOPPurchase+715$691.79+$494.6K+5.1%14.7K after
Aug 14, 2025 (view filing)Aug 131 dayAlvarez RalphDirectorPPurchase+758$660.25+$500.5KNew position758 after
Aug 13, 2025 (view filing)Aug 13Same dayVan Naarden JacobEVP & Pres., Lilly OncologyPPurchase+1.00K$647.36+$647.4K+5.1%20.6K after
Aug 12, 2025 (view filing)Aug 12Same dayRicks David APresident, Chair, and CEOPPurchase+1.63K$644.77+$1.05M+0.3%546.6K after
Aug 12, 2025 (view filing)Aug 12Same daySkovronsky DanielEVP, CSO & Pres. LRL & LLY ImmPPurchase+1.00K$634.41+$634.4K+0.7%137.7K after
Aug 12, 2025 (view filing)Aug 12Same daySulzberger GabrielleDirectorPPurchase+117$641.18+$75.0K+4.5%2.70K after
Aug 12, 2025 (view filing)Aug 12Same dayFyrwald J ErikDirectorPPurchase+1.56K$642.33+$1.01M+2.1%74.6K after2 lots
Aug 12, 2025 (view filing)Aug 111 dayYuffa IlyaEVP&Pres, LLY USA&Global CapabSSale−1.25K$627.01−$783.8K−4.5%26.3K after10b5-1